908 Devices (MASS) Share-based Compensation Growth (1y) (2021 - 2026)
908 Devices (MASS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 12.94% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 59.09% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | -30.44% |
| 10 | 908 Devices | 269.51 Mn | 157.77 Mn | 6.88 Mn | 440.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 440.54% |
| Dec 31, 2025 | 619.01% |
| Sep 30, 2025 | 326.09% |
| Jun 30, 2025 | 4.80% |
| Mar 31, 2025 | 20.72% |
| Dec 31, 2024 | -121.59% |
| Sep 30, 2024 | -14.94% |
| Jun 30, 2024 | -13.54% |
| Mar 31, 2024 | -15.10% |
| Dec 31, 2023 | 16.72% |
| Sep 30, 2023 | 33.86% |
| Jun 30, 2023 | 36.11% |
| Mar 31, 2023 | 68.04% |
| Dec 31, 2022 | 129.55% |
| Sep 30, 2022 | 149.08% |
| Jun 30, 2022 | 293.76% |
| Mar 31, 2022 | 280.24% |
| Dec 31, 2021 | 184.36% |
| Sep 30, 2021 | 877.11% |
| Jun 30, 2021 | 597.10% |